DIAMOND's @jessicagoml.bsky.social presents her work on how gap choice affects estimates of benzodiazepine and Z‑drug discontinuation in dispensing data. #ISPEAnnual2026 #DIAMOND #deprescribing #DePhaRM
DIAMOND Research Programme
@diamond-derx.bsky.social
Innovating Methods | Advancing Deprescribing Based at RCSI (https://bsky.app/profile/rcsi.bsky.social), led by Prof Frank Moriarty (@frankmoriarty.bsky.social) and funded by Wellcome. Find out more about our work here: https://diamond-deprescribing.eu/
The final day of #ISPEAnnual2026 shows no signs of losing momentum — a diverse programme packed with sessions on treatment‑effect heterogeneity, drug utilisation, neuropsychiatric safety, modern disease‑course epidemiology, real‑world economics, and more. #DIAMOND #deprescribing
Our #DePhaRM colleague Dr Zakir Khan shared a stratified disproportionality analysis on signals for adverse drug withdrawal events across US and EU pharmacovigilance databases. #ISPEAnnual2026 #DIAMOND #deprescribing #DePhaRM
Our #DePhaRM colleague Alex McKibben shared a comparative analysis of medication counting approaches in national dispensing data — a cohort study with important implications for exposure measurement. #ISPEAnnual2026 #DIAMOND #deprescribing
DIAMOND's Dr Anais Essilini presents her work validating new approaches to identify serotonin syndrome in pharmacovigilance data. #ISPEAnnual2026 #DIAMOND #deprescribing #DePhaRM
Day 2 of #ISPEAnnual2026 continues with a jam-packed programme for the day ahead including oral and poster presentations, symposia and workshops, panels and a hot topics session. #DIAMOND #deprescribing #DePhaRM
DIAMOND's Dr Ryan Muddiman delivering an oral presentation on analysing prescription intervals in primary care to inform drug‑specific exposure time. #ISPEAnnual2026 #DIAMOND #deprescribing #DePhaRM
Our #DePhaRM colleague Dr Constanza Saka showcases a systematic review on the accuracy of diagnostic codes and algorithms for identifying systemic lupus erythematosus in EHRs. Poster on display at Exhibit Hall, A‑290. #ISPEAnnual2026 #DIAMOND #deprescribing
Also presenting a poster at #ISPEAnnual2026 is #DIAMOND's Dr Ryan Muddiman, who shares findings from a simulation study comparing methods to estimate deprescribing effectiveness from observational data. You can catch Ryan at A-242 in the Exhibit Hall.
DIAMOND's Dr @annsinead.bsky.social presents her work on prescribing cascades in Dutch older adults using routine GP data. You can visit her poster in the Exhibit Hall, A‑183. #ISPEAnnual2026 #DIAMOND #deprescribing #DePhaRM
A thought-provoking start to Day 1 at #ISPEAnnual2026 with the keynote from Peter Arlett of the European Medicines Agency. Peter highlighted the context that influences the real world and thus real world data, with implications for future evidence generation #DIAMOND #deprescribing
Gianluca Trifirò, Scientific Program Chair of #ISPEAnnual2026, outlining Italy's long standing history in pharmacoepidemiology #DIAMOND #deprescribing
Day 1 of #ISPEAnnual2026 begins with an opening address from ISPE President Ursula Kirchmayer who welcomed attendees to Milan
Posters, panels, poutine – that's a wrap for the DIAMOND, DePhaRM & RCSI contingent ! #ICOD2026 #DIAMOND #deprescribing
A whirlwind few days at #ICOD2026 packed with diverse topics & engaging #deprescribing discussions. Plenty for the #DIAMOND team to reflect on as we return to Ireland. Thanks to @caden-recad.bsky.social , @deprescribeus.bsky.social & the #ICOD2026 planning committee for such an engaging event
Clare Howard delivering the #ICOD2026 closing keynote "Research versus the real world: getting the balance right" by passionately outlining the great work done in England including data-driven insights & the polypharmacy action learning sets. An inspiring end to #ICOD2026 #DIAMOND #deprescribing
#ICOD2026 continues with a breadth sessions to choose from including panels & workshops on sedative use, paediatric psychotropic polypharmacy, evidence-based & inclusive tools for deprescribing &implementation science approaches to stakeholder-informed interventions #DIAMOND #deprescribing
#ICOD2026 continues with the concurrent sessions. DePhaRM colleague Zakir Khan delivering an oral presentation on his overview of reviews that examined adverse drug withdrawal reactions after medication discontinuation, part of the HEAD-P project. #DIAMOND #deprescribing
#DIAMOND's Ryan Muddiman presenting again today with findings from a cohort study examining medication interval patterns amongst older adults in primary care #deprescribing #ICOD2026
DePhaRM's Alex McKibben presents findings from her systematic review of international guidelines to identify patients for medication review in primary care. #ICOD2026 #DIAMOND #deprescribing
DePhaRM's Zakir Khan presenting his work on adverse drug withdrawal events reported in US & EU pharmacovigilance databases #DIAMOND #deprescribing #ICOD2026
#DIAMOND's Anais Essilini presenting findings from an overview of reviews on medications associated with serotonin syndrome. Her work underscores the challenges of evidence synthesis for rare serious adverse events where reports are dominated by case reports #ICOD2026 #DIAMOND #deprescribing
The morning kicking off with a plenary talk from Muhammad Mamdani on Applied AI in healthcare and the implications for #deprescribing, with #DIAMOND PI @frankmoriarty.bsky.social delivering the speaker introduction
DIAMOND's @annsinead.bsky.social joins James Sheppard and John Tazare on a panel moderated by DIAMOND's @frankmoriarty.bsky.social to explore methodological challenges in studying deprescribing with real-world data. Lots of interest in this discussion. #ICOD2026 #DIAMOND #deprescribing
RCSI colleague and member of @frankmoriarty.bsky.social's DePhaRM group, Zakir Khan joins Ariel Green, Shin Liau, and Orla Sheehan for a panel discussion, moderated by @reeve-research.bsky.social on understanding adverse drug withdrawal events in #deprescribing. #ICOD2026 #DIAMOND
Another RCSI colleague, Caroline McCarthy, now moderating a Fireside Chat with Ross Upshur on "Becoming what you research" at #ICOD2026. #DIAMOND #deprescribing
Also lovely to get a chance to catch up with other RCSI colleagues at #ICOD2026. A networking lunch on "Health literacy and deprescribing" today which is moderated by RCSI's Patrick Moynagh #DIAMOND #deprescribing
#ICOD2026 continues with the scientific abstracts plenary. Diverse topics including #deprescribing prophylactic antibiotics for UTIs, comparing HCP application of STOPP/START, meds management in cognitively impaired older adults, antihypertensive deprescribing and strengthening pharmacovigilance
Ryan Muddiman presenting a poster examining several estimation approaches in #deprescribing using simulation methods. He generated complex event history data resembling EHR data & measured performance when targeting specific estimands of stopping medication vs. continued use #ICOD2026